Antony B. Friedman

868 total citations
32 papers, 539 citations indexed

About

Antony B. Friedman is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Antony B. Friedman has authored 32 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 13 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Antony B. Friedman's work include Inflammatory Bowel Disease (26 papers), Microscopic Colitis (13 papers) and Acute Lymphoblastic Leukemia research (7 papers). Antony B. Friedman is often cited by papers focused on Inflammatory Bowel Disease (26 papers), Microscopic Colitis (13 papers) and Acute Lymphoblastic Leukemia research (7 papers). Antony B. Friedman collaborates with scholars based in Australia, Italy and United States. Antony B. Friedman's co-authors include Peter G. Gibson, Kirstin M. Taylor, Giovanni Maconi, Miles Sparrow, Anil Kumar Asthana, Rebecca L. Smith, Christian Maaser, Torsten Kucharzik, Robert N. Gibson and Peter R. Gibson and has published in prestigious journals such as Gastroenterology, Gut and Gastrointestinal Endoscopy.

In The Last Decade

Antony B. Friedman

28 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antony B. Friedman Australia 13 408 304 195 113 70 32 539
F de Voogd Netherlands 13 439 1.1× 334 1.1× 262 1.3× 147 1.3× 21 0.3× 36 541
C. Rigazio Italy 11 321 0.8× 268 0.9× 199 1.0× 113 1.0× 22 0.3× 29 473
G. Vernier‐Massouille France 8 393 1.0× 299 1.0× 265 1.4× 24 0.2× 68 1.0× 12 590
Jelle G. Goedhard Netherlands 8 226 0.6× 196 0.6× 216 1.1× 41 0.4× 38 0.5× 13 441
Yoon‐Kyo An Australia 9 224 0.5× 179 0.6× 140 0.7× 29 0.3× 53 0.8× 24 329
I. Arnott United Kingdom 7 269 0.7× 177 0.6× 208 1.1× 23 0.2× 32 0.5× 19 435
Linda Tang Australia 4 476 1.2× 392 1.3× 239 1.2× 17 0.2× 42 0.6× 7 575
E. Makó Hungary 7 263 0.6× 171 0.6× 219 1.1× 79 0.7× 11 0.2× 15 483
Nina Levhar Israel 13 414 1.0× 211 0.7× 318 1.6× 20 0.2× 35 0.5× 23 596
Zsolt Tarján Hungary 7 206 0.5× 155 0.5× 150 0.8× 50 0.4× 11 0.2× 10 389

Countries citing papers authored by Antony B. Friedman

Since Specialization
Citations

This map shows the geographic impact of Antony B. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antony B. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antony B. Friedman more than expected).

Fields of papers citing papers by Antony B. Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antony B. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antony B. Friedman. The network helps show where Antony B. Friedman may publish in the future.

Co-authorship network of co-authors of Antony B. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Antony B. Friedman. A scholar is included among the top collaborators of Antony B. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antony B. Friedman. Antony B. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gibson, Peter R., Kirstin M. Taylor, Ellen Anderson, et al.. (2025). Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial. Alimentary Pharmacology & Therapeutics. 61(8). 1276–1289. 7 indexed citations
2.
3.
Bezzio, Cristina, Simone Saibeni, Marta Vernero, et al.. (2024). The learning curve for using intestinal ultrasonography. Digestive and Liver Disease. 56(9). 1511–1516. 10 indexed citations
4.
Taylor, Kirstin M., et al.. (2024). Ultrasound assessment of gastrointestinal luminal contents: a narrative review. Journal of Ultrasound. 27(4). 781–792. 3 indexed citations
5.
6.
7.
Vasudevan, Abhinav, Danny Con, Peter De Cruz, et al.. (2023). Clinical trial: Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study). Alimentary Pharmacology & Therapeutics. 59(4). 504–514. 6 indexed citations
8.
Friedman, Antony B., et al.. (2022). Resistive small bowel bleeding secondary to an arteriovenous malformation. ANZ Journal of Surgery. 93(1-2). 376–378.
9.
Smith, Rebecca L., et al.. (2021). Interrater reliability of the assessment of disease activity by gastrointestinal ultrasound in a prospective cohort of patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 33(10). 1280–1287. 6 indexed citations
10.
Smith, Rebecca L., et al.. (2021). Early Assessment With Gastrointestinal Ultrasound in Patients Hospitalised for a Flare of Ulcerative Colitis and Predicting the Need for Salvage Therapy: A Pilot Study. Ultrasound in Medicine & Biology. 47(4). 1108–1114. 17 indexed citations
11.
Ardalan, Zaid, Antony B. Friedman, Danny Con, et al.. (2021). Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation and its Location in Patients with an Ileoanal Pouch. Journal of Crohn s and Colitis. 16(1). 79–90. 19 indexed citations
12.
Smith, Rebecca L., et al.. (2020). P245 Inter-rater reliability of gastrointestinal ultrasound in the assessment of disease activity in patients with inflammatory bowel disease prior to commencing medical therapy. Journal of Crohn s and Colitis. 14(Supplement_1). S269–S271. 2 indexed citations
13.
Friedman, Antony B., Steven J. Brown, Peter A. Bampton, et al.. (2018). Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders ( AAA Study). Alimentary Pharmacology & Therapeutics. 47(8). 1092–1102. 32 indexed citations
14.
Vasudevan, Abhinav, Lauren Beswick, Antony B. Friedman, et al.. (2018). Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease. Digestive and Liver Disease. 50(7). 682–688. 19 indexed citations
15.
Bryant, Robert V., Antony B. Friedman, Emily K. Wright, et al.. (2018). Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. Gut. 67(5). 973–985. 121 indexed citations
16.
Day, Andrew S., Susan J. Connor, Steven T. Leach, et al.. (2017). Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse. Gastrointestinal Endoscopy. 86(6). 1070–1078. 38 indexed citations
17.
Beswick, Lauren, Jamie P. Dwyer, Antony B. Friedman, et al.. (2014). P534 Co-prescription of allopurinol can overcome adverse events of thiopurine therapy and lead to remission in inflammatory bowel disease patients. Journal of Crohn s and Colitis. 8. S290–S291. 1 indexed citations
18.
Beswick, Lauren, Antony B. Friedman, & Miles Sparrow. (2014). The role of thiopurine metabolite monitoring in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology. 8(4). 383–392. 16 indexed citations
19.
Maconi, Giovanni, et al.. (2014). Accuracy and cost of diagnostic strategies for patients with suspected Crohn's disease. Journal of Crohn s and Colitis. 8(12). 1684–1692. 36 indexed citations
20.
Day, Andrew S., Susan J. Connor, Steven T. Leach, et al.. (2012). 970 Multicenter Capsule Endoscopy Study of Small Bowel Crohn's Disease Patients in Clinical Remission: Long-Term Follow-up and Correlation With Faecal Biomarkers and Clinical Outcome. Gastroenterology. 142(5). S–169. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F de Voogd Breakdown of academic impact, for papers by C. Rigazio Breakdown of academic impact, for papers by G. Vernier‐Massouille Breakdown of academic impact, for papers by Jelle G. Goedhard Breakdown of academic impact, for papers by Yoon‐Kyo An Breakdown of academic impact, for papers by I. Arnott Breakdown of academic impact, for papers by Linda Tang Breakdown of academic impact, for papers by E. Makó Breakdown of academic impact, for papers by Nina Levhar Breakdown of academic impact, for papers by Zsolt Tarján
Rankless by CCL
2026